Laura Campogiani
-
- Antibiotic Use and Resistance 5
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 5
-
- SARS-CoV-2 and COVID-19 Research 6
- COVID-19 Clinical Research Studies 4
-
- Pneumonia and Respiratory Infections 5
- Pneumocystis jirovecii pneumonia detection and treatment 4
-
- Antibiotics Pharmacokinetics and Efficacy 4
-
- Clinical practice guidelines implementation 3
Laura Campogiani
29 papers receiving 219 citations
Peers
Comparison fields: 5 of 58
- Applied Microbiology and Biotechnology 24
- Molecular Medicine 42
- Infectious Diseases 95
- Clinical Biochemistry 16
- Neurology 35
Countries citing papers authored by Laura Campogiani
This map shows the geographic impact of Laura Campogiani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Campogiani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Campogiani more than expected).
Fields of papers citing papers by Laura Campogiani
This network shows the impact of papers produced by Laura Campogiani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Campogiani. The network helps show where Laura Campogiani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laura Campogiani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 14 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 11 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 5 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 27 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 19 | |
| 15 | 2021 | 6 | |
| 16 | 2020 | 6 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 2 | |
| 19 | 2019 | 12 | |
| 20 | 2019 | 8 |
About Laura Campogiani
Laura Campogiani is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 32 papers that have together received 222 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Pneumonia and Respiratory Infections (5 papers), Antibiotic Use and Resistance (5 papers), Antibiotic Resistance in Bacteria (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), COVID-19 Clinical Research Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Clinical practice guidelines implementation (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (24 citations), Molecular Medicine (42 citations) and Infectious Diseases (95 citations). Laura Campogiani has collaborated with scholars based in Italy, Spain and France. Frequent co-authors include Jordi Rello, Loredana Sarmati, Sofía Tejada, Massimo Andreoni, Vincenzo Malagnino, Elisabetta Teti, Marco Iannetta, João Ferreira‐Coimbra, Daniela Fraboni and Francesco Buccisano. Their work appears in journals such as Scientific Reports, Frontiers in Immunology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.